Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Eisai discovers novel selective PDE I inhibitor

March 19, 1997

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

Novel Na+/H+-exchange inhibitor from Fujisawa with cardioprotective effects

March 19, 1997

Cardioprotective effects of KBR-9032

March 19, 1997

Gastric prokinetic agent developed by Kyorin

March 19, 1997

Potent, nonselective adenosine agonist from Schering-Plough

March 17, 1997

Water-soluble HIV protease inhibitor from Sankyo

March 14, 1997

Novo Nordisk characterizes potential antipsychotic agent

March 11, 1997

Novel LT biosynthesis inhibitor discovered by Abbott

March 11, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...